CYP1B1 C-terminal Antibody

Skip to product information
1 of 1

Selleck Chemicals

SKU:F2488-20UL

Regular price €199,00 EUR
Regular price Sale price €199,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

CYP1B1 C-terminal is a cytochrome P450 enzyme with a critical C-terminal region that contributes to the protein’s structural stability and enzymatic activity. The C-terminal domain contains conserved elements essential for heme binding, substrate recognition, and catalytic activity. Structurally, this region helps form part of the enzyme’s active site and stabilizes the tertiary fold of the P450 architecture. Depending on the literature source, CYP1B1 may also be discussed as CYP1B1 C-terminal and Cytochrome P450 1B1.

Reported cellular context includes endoplasmic reticulum, membrane, microsome, and mitochondrion, which can matter when signal is compared across treatments or changing cell states. Following CYP1B1 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CYP1B1 is commonly interpreted in the context of cancer research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans endoplasmic reticulum, membrane, and microsome, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between endoplasmic reticulum, membrane, and microsome across matched conditions
  • changes associated with proliferative state, oncogenic signaling, or treatment response
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CYP1B1. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CYP1B1 reflect biology rather than handling. When interpreting CYP1B1, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CYP1B1 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
CYP1B1
Research Area:
Cancer
Application:
IHC • WB
Reactivity:
Human • Rat
Specificity:
CYP1B1 C-terminal Antibody [J21C16] recognizes endogenous levels of total CYP1B1-C protein.
Host:
Rabbit
Clonality:
Monoclonal
Clone:
J21C16
UniProt:
Q16678
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.